人口因素和胆管:一个儿童肝病研究网络研究的研究
Zachary J Kastenberg1, Charlotte A Beil2, Lisa Henn2
1Department of Surgery, Division of Pediatric Surgery, Intermountain Primary Children's Hospital, University of Utah, Salt Lake City, Utah.
Pediatrics
|February 18, 2026
概括
社区贫困,种族和种族与肝脏输肠口切除手术的较低率和胆道缩的婴儿的延迟手术有关. 这些因素,以及临床变量,影响手术成功和本地肝脏存活率.
科学领域:
- 儿科手术 儿科手术
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
背景情况:
- 胆管缩是一种严重的新生儿肝病,需要及时的手术干预.
- 社会经济和种族差异可能会影响儿童肝脏疾病的治疗机会和治疗结果.
- 肝输肠静脉切除术是胆道缩的主要手术治疗方法.
研究的目的:
- 调查社区贫困,种族和种族之间的联系,以及接受肝脏输肠口切除术的可能性.
- 检查这些人口因素对胆道缩手术时年龄的影响.
- 为了确定人口统计学,临床或解剖学变量是否会影响患有胆道的婴儿手术成功和本源肝脏存活率.
主要方法:
- 来自儿童肝病研究网络 (ChiLDReN) 的胆道缩的婴儿前性注册队列的分析.
- 包括719名婴儿反映了美国人口统计数据.
- 利用线性回归和逻辑回归来测试变量与手术结果之间的关联.
主要成果:
- 社区贫困,亚洲种族和西班牙裔种族与接受肝脏输肠口切除术的可能性降低有关.
- 增加的社区贫困与晚年发生的肝脏输肠口术相关.
- 与白人婴儿相比,黑人/非洲裔美国婴儿在手术时的年龄要大得多.
结论:
- 社区的贫困,种族和族裔显著影响了胆道缩的婴儿肝移植肠静脉切除术的速率和时间.
- 临床和解剖学因素与成功的胆汁排水和本地肝脏存活更强烈相关.
- 解决社会经济和种族差异对于改善儿科肝病的结果至关重要.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
213
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
344
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
344
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258


